Research on geophysical response analysis and prediction technology of geostress in the shale gas area of the southern Sichuan Basin

The exploration and development potential of shale gas reservoirs in the Sichuan Basin is enormous; however, it also faces difficulties such as complex structures, strong heterogeneity, and unclear geophysical response characteristics. Fine prediction of geostress is an important part of shale gas exploration and development, which directly affects the implementation effect of reservoir evaluation, well trajectory design, and fracture reconstruction. The existing geostress prediction techniques lack high-precision seismic data constraints, making it difficult to accurately reflect the planar distribution characteristics of geostress in the block with rapid changes in complex tectonic zones. At the same time, the geophysical response characteristics of geostress in the Sichuan Basin are unknown, and the geostress seismic prediction technology lacks theoretical basis. This paper combines numerical simulation and physical experiments and defines the characteristics of the geophysical response of shale gas reservoirs in the Sichuan Basin changing with the stress field, and technical countermeasures for geostress seismic prediction have been established to provide technical means for accurate prediction of the geostress field in the shale gas block. Based on the geostress sensitive parameters obtained from prestack seismic inversion, the geostress field prediction of a shale gas work area in the Sichuan Basin is realized

Recombinant Goat VEGF164 Increases Hair Growth by Painting Process on the Skin of Shaved Mouse

To detect goat vascular endothelial growth factor (VEGF)-mediated regrowth of hair, full-length VEGF164 cDNA was cloned from Inner Mongolia cashmere goat (Capra hircus) into the pET-his prokaryotic expression vector, and the recombinant plasmid was transferred into E. coli BL21 cells. The expression of recombinant 6×his-gVEGF164 protein was induced by 0.5 mM isopropyl thio-β-D-galactoside at 32°C. Recombinant goat VEGF164 (rgVEGF164) was purified and identi ed by western blot using monoclonal anti-his and anti-VEGF antibodies. The rgVEGF164 was smeared onto the dorsal area of a shaved mouse, and we noted that hair regrowth in this area was faster than in the control group. Thus, rgVEGF164 increases hair growth in mice

Confined Crystallization of Pigment Red 146 in Emulsion Droplets and Its Mechanism

In this work, the effect of confined space on crystallization processes of pigments was investigated by using C.I. Pigment Red 146 (PR 146) as a model compound. The colloidal system (i.e., emulsion droplets) was used as a nanoreactor to prepare nanoscale PR 146 for the inkjet printer. The effects of the space confinement were investigated by comparing the products of PR 146 prepared from bulk solution, macroemulsion, and miniemulsion. The results showed that PR 146 crystallized in mini-emulsion had the narrowest particle size distribution and the average particle size can be as small as 172.5 nm, one order of magnitude smaller than the one obtained from the bulk solution. X-ray diffraction (XRD) data revealed that PR 146 crystallized in all three solutions where the crystalline state and had similar crystallite sizes. The process mechanism of crystallization confined in the miniemulsion droplets was proposed and explained. The function mechanism of the co-stabilizer during the crystallization of PR 146 in emulsion was also explained. It was found that sodium chloride could counteract the pressure difference as an osmotic pressure agent and prevent the migrating of water from small droplets into big droplets. The influences of dosages of emulsifiers and co-stabilizers on droplet size and the size of the obtained PR 146 particles were evaluated and the optimal conditions were determined. Furthermore, the disparity of PR 146 products prepared by different methods was investigated by UV–Vis spectra. The aqueous dispersion of PR 146 crystallized in miniemulsion had the highest absorbance and darkest color

Baicalein Induces Apoptosis and Autophagy via Endoplasmic Reticulum Stress in Hepatocellular Carcinoma Cells

Background. Hepatocellular carcinoma (HCC) remains a disastrous disease and the treatment for HCC is rather limited. Separation and identification of active compounds from traditionally used herbs in HCC treatment may shed light on novel therapeutic drugs for HCC. Methods. Cell viability and colony forming assay were conducted to determine anti-HCC activity. Morphology of cells and activity of caspases were analyzed. Antiapoptotic Bcl-2 family proteins and JNK were also examined. Levels of unfolded protein response (UPR) markers were determined and intracellular calcium was assayed. Small interfering RNAs (siRNAs) were used to investigate the role of UPR and autophagy in baicalein-induced cell death. Results. Among four studied flavonoids, only baicalein exhibited satisfactory inhibition of viability and colony formation of HCC cells within water-soluble concentration. Baicalein induced apoptosis via endoplasmic reticulum (ER) stress, possibly by downregulating prosurvival Bcl-2 family, increasing intracellular calcium, and activating JNK. CHOP was the executor of cell death during baicalein-induced ER stress while eIF2α and IRE1α played protective roles. Protective autophagy was also triggered by baicalein in HCC cells. Conclusion. Baicalein exhibits prominent anti-HCC activity. This flavonoid induces apoptosis and protective autophagy via ER stress. Combination of baicalein and autophagy inhibitors may represent a promising therapy against HCC

DNA methylation patterns of protein-coding genes and long non-coding RNAs in males with schizophrenia

Schizophrenia (SCZ) is one of the most complex mental illnesses affecting 1% of the population worldwide. SCZ pathogenesis is considered to be a result of genetic as well as epigenetic alterations. Previous studies have aimed to identify the causative genes of SCZ. However, DNA methylation of long non-coding RNAs (lncRNAs) involved in SCZ has not been fully elucidated. In the present study, a comprehensive genome-wide analysis of DNA methylation was conducted using samples from two Male patients with paranoid and undifferentiated SCZ, respectively. Methyl-CpG binding domain protein-enriched genome sequencing was used. In the two patients with paranoid and undifferentiated SCZ, 1,397 and 1,437 peaks were identified, respectively. Bioinformatic analysis demonstrated that peaks were enriched in protein-coding genes, which exhibited nervous system and brain functions. A number of these peaks in gene promoter regions may affect gene expression and, therefore, influence SCZ-associated pathways. Furthermore, 7 and 20 lncRNAs, respectively, in the Refseq database were hypermethylated. According to the lncRNA dataset in the NONCODE database, similar to 30% of intergenic peaks overlapped with novel lncRNA loci. The results of the present study demonstrated that aberrant hypermethylation of lncRNA genes may be an important epigenetic factor associated with SCZ. However, further studies using larger sample sizes are required

Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial

Abstract Background Relapsed or refractory acute myeloid leukemia (R/R AML) has a dismal prognosis. The aim of this study was to investigate the activity and tolerability of venetoclax combined with azacitidine plus homoharringtonine (VAH) regimen for R/R AML. Methods This phase 2 trial was done at ten hospitals in China. Eligible patients were R/R AML (aged 18–65 years) with an Eastern Cooperative Oncology Group performance status of 0–2. Patients received venetoclax (100 mg on day 1, 200 mg on day 2, and 400 mg on days 3–14) and azacitidine (75 mg/m2 on days 1–7) and homoharringtonine (1 mg/m2 on days 1–7). The primary endpoint was composite complete remission rate [CRc, complete response (CR) plus complete response with incomplete blood count recovery (CRi)] after 2 cycles of treatment. The secondary endpoints include safety and survival. Results Between May 27, 2020, and June 16, 2021, we enrolled 96 patients with R/R AML, including 37 primary refractory AML and 59 relapsed AML (16 relapsed after chemotherapy and 43 after allo-HSCT). The CRc rate was 70.8% (95% CI 60.8–79.2). In the patients with CRc, measurable residual disease (MRD)-negative was attained in 58.8% of CRc patients. Accordingly, overall response rate (ORR, CRc plus partial remission (PR)) was 78.1% (95% CI 68.6–85.4). At a median follow-up of 14.7 months (95% CI 6.6–22.8) for all patients, median overall survival (OS) was 22.1 months (95% CI 12.7–Not estimated), and event-free survival (EFS) was 14.3 months (95% CI 7.0–Not estimated). The 1-year OS was 61.5% (95% CI 51.0–70.4), and EFS was 51.0% (95% CI 40.7–60.5). The most common grade 3–4 adverse events were febrile neutropenia (37.4%), sepsis (11.4%), and pneumonia (21.9%). Conclusions VAH is a promising and well-tolerated regimen in R/R AML, with high CRc and encouraging survival. Further randomized studies are needed to be explored. Trial registration clinicaltrials.gov identifier: NCT04424147

Characteristics of 106 subjects.

<p>Characteristics of 106 subjects.</p